首页> 外国专利> METHODS FOR LOW TEMPERATURE FLUORINE-18 RADIOLABELING OF BIOMOLECULES

METHODS FOR LOW TEMPERATURE FLUORINE-18 RADIOLABELING OF BIOMOLECULES

机译:生物分子的低温氟18放射性标记方法

摘要

New chelators such as H3L1, H3L2, H3L3, H3L26 and derivatives were synthesized for the complexation of {Al18F}2+. These new chelators are able to complex {AI18F}2+ with good radiochemical yields using a labeling temperature of 37° C. The stability of the new Al18F-complexes was tested in phosphate buffered saline (PBS) at pH 7 and in rat serum. AI18F-L3 and AI18F-L26 showed a stability comparable to that of the previously reported Al18F-NODA. Moreover, the biodistribution of Al18F-L3 and Al18F-L26 showed absence of in vivo demetallation since only very limited bone uptake was observed, whereas the major fraction of activity 60 min p.i. was observed in liver and intestine due to hepatobiliary clearance of the radiolabeled ligand. The chelators H3L3 and Al18F-L26 demonstrated to be a good lead candidates for the labeling of heat sensitive biomolecules with 18F-fluorine and derivatives have been synthesized. We have explored the complexation of {AI18F}2+ with new chelators and obtained very favourable radiochemical yields (85%) using a labeling temperature of 37° C. The stability of the new Al18F-complexes was tested in phosphate buffered saline (PBS) at pH 7 and in rat serum at 37° C., where AI18F-L3 and AI18F-L26 showed a stability comparable to that of the previously reported Al18F-NODA. Moreover, the biodistribution of Al18F-L3 and Al18F-L26 showed high stability, since only very limited bone uptake—which would be an indication of release of fluorine-18 in the form of fluoride—was observed, whereas the major fraction of activity 60 min p.i. was observed in liver and intestines due to hepatobiliary clearance of the radiolabeled ligand. The chelators H3L3 and H3L26 demonstrated to be good lead candidates for the labeling of heat sensitive biomolecules with 18F-fluorine and several derivatives have been synthesized.
机译:合成了新的螯合剂,例如H3L1,H3L2,H3L3,H3L26及其衍生物,用于{Al18F} 2+的络合。这些新的螯合剂能够在37°C的标记温度下以良好的放射化学产率络合{AI18F} 2+。在pH 7的磷酸盐缓冲盐水(PBS)和大鼠血清中测试了新的Al18F复合物的稳定性。 AI18F-L3和AI18F-L26显示出与以前报道的Al18F-NODA相当的稳定性。此外,Al18F-L3和Al18F-L26的生物分布显示缺乏体内脱金属,因为仅观察到非常有限的骨骼摄取,而主要活性部分在p.i 60分钟。由于放射性标记的配体的肝胆清除作用,在肝脏和肠道中观察到了“异体”。螯合剂H3L3和Al18F-L26被证明是用18F-氟标记热敏生物分子的良好先导候选物,并且已经合成了衍生物。我们已经探索了{AI18F} 2+与新型螯合剂的络合,并在37°C的标记温度下获得了非常有利的放射化学收率(> 85%)。在磷酸盐缓冲盐水(PBS)中测试了新型Al18F复合物的稳定性。 )在pH 7和在37℃的大鼠血清中,其中AI18F-L3和AI18F-L26显示出与先前报道的Al18F-NODA相当的稳定性。此外,Al18F-L3和Al18F-L26的生物分布显示出高稳定性,因为仅观察到非常有限的骨骼吸收(这将表明氟18以氟的形式释放),而活性的主要部分60敏皮由于放射性标记的配体具有肝胆清除作用,因此在肝脏和肠道中观察到了这种现象。螯合剂H3L3和H3L26被证明是用18F-氟标记热敏生物分子的良好先导候选物,已经合成了几种衍生物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号